This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Scott Gottlieb, M.D., Commissioner of Food and Drugs

Event Date: 10/09/2018
Location: Silver Spring, MD
Subject: Laguna Biotech Annual CEO Forum
FDA Participant/Group: PETER STEIN;
Non FDA Participant/Group: Industry, academia, government, and other registered guests

Event Date: 10/09/2018
Location: Silver Spring, MD
Subject: Batten Disease
FDA Participant/Group: JOHN MARTIN; LAUREN SILVIS;
Non FDA Participant/Group: Julia Vitarello (Mila's Miracle Foundation); Tim Yu (Boston Children's Hospital);

Event Date: 10/11/2018
Location: Silver Spring, MD
Subject: Company Actions to Address Youth Use of E-Cigarettes
FDA Participant/Group: CARLYLE MCWILLIAMS; STACY AMIN; ANNA ABRAM; RANDALL LUTTER; LAUREN SILVIS; JOSEPHINE TROPEA; MITCHELL ZELLER; LAUREN ROTH; MICHELE MITAL; ROBIN APPLEBERRY; ANN SIMONEAU; LINDSAY TOBIAS; IMELDA PAREDES; DAVID MEDNICK;
Non FDA Participant/Group: Jeff Raborn, Jim Figlar, Joe Fragnito, MItch Neuhauser, Mike Ogden, Ricardo Oberlander, Rich Haselwood (Reynolds American Incorparted);

Official Name: Rachel Sherman, M.D., M.P.H., Principal Deputy Commissioner

No Significant Event

Official Name: Anna Abram, Deputy Commissioner for Policy, Planning, Legislation, and Analysis

No Significant Event

Official Name: Mark Abdoo, Acting Deputy Commissioner for Global Regulatory Operations and Policy

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Stephen M. Ostroff, M.D., Deputy Commissioner for Foods and Veterinary Medicine

No Significant Event

Official Name: Melinda Plaisier, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Mary Lou Valdez, M.S.M., Associate Commissioner for International Programs

No Significant Event

Official Name: Jennifer Rodriguez, Acting Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 10/10/2018
Location: Silver Spring, MD
Subject: International Plasma Fractionation Association (IPFA)/FDA Liaison Meeting
FDA Participant/Group: Several CBER officials and staff members
Non FDA Participant/Group: Several respresentatives from the International Plasma Fractionation Association

Event Date: 10/12/2018
Location: Boston, MA
Subject: American Association of Blood Banks (AABB) Pre-Meeting Workshop
FDA Participant/Group: N/A
Non FDA Participant/Group: Several representatives from the transfusion medicine and cellular therapies industry and healthcare professionals

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Susan T. Mayne Ph.D., Director, Center for Food Safety and Applied Nutrition

Event Date: 10/11/2018
Location: College Park, MD
Subject: Peanuts, Tree Nuts, and Acrylamide
FDA Participant/Group: PAUL SOUTH; LAUREN ROBIN; ROBIN MCKINNON; SUSAN BERNARD; DOUGLAS BALENTINE; PETER BECKERMAN; LAURA CARROLL;
Non FDA Participant/Group: Martin Hahn (Hogan Lovells LLP); Jeannie Shaughnessy (Peanut and Tree Nut Processors Association);

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Stacy Cline Amin, Chief Counsel

No Significant Event